Drug intelligence / Profile preview

Aldevit Gold Sachet

Development stage: Unknown
Lead developer: Alde Medi Impex
Modality: Small Molecules
Administration: Oral

Overview

Aldevit Gold Sachet is an approved combination nutraceutical formulation developed by Alde Medi Impex. It is formulated with a synergistic blend of active ingredients, including lycopene, mecobalamin (methylcobalamin), coenzyme Q10 (CoQ10), and L-arginine. This combination is designed to provide comprehensive antioxidant support, enhance cellular energy production, promote cardiovascular health, and support neurological function. It is typically administered orally as a sachet dissolved in water to address nutritional deficiencies, combat oxidative stress, and support overall vitality and metabolic well-being.

Brand names: Aldevit Gold Sachet
Other names: coenzyme Q10 + L-arginine + lycopene + mecobalamincoenzyme Q10 + L-arginine + lycopene + methylcobalamin

Targets

MTR (Methionine synthase)NOS1 (nNOS)

Beyond the preview

Go deeper on Aldevit Gold Sachet.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aldevit Gold Sachet.